product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Jagged1 (D4Y1R) XP Rabbit mAb
catalog :
70109
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D4Y1R
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry - paraffin section
more info or order :
Cell Signaling Technology product webpage
citations: 6
Published Application/Species/Sample/DilutionReference
  • western blot; mouse; loading ...; fig 3g
Liu C, Chen Q, Shang Y, Chen L, Myers J, Awadallah A, et al. Endothelial PERK-ATF4-JAG1 axis activated by T-ALL remodels bone marrow vascular niche. Theranostics. 2022;12:2894-2907 pubmed publisher
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 4a
Chiremba T, Neufeld K. Constitutive Musashi1 expression impairs mouse postnatal development and intestinal homeostasis. Mol Biol Cell. 2021;32:28-44 pubmed publisher
  • western blot; human; loading ...; fig 2f, s3a
Lin Q, Chen X, Meng F, Ogawa K, Li M, Song R, et al. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Mol Cancer. 2019;18:156 pubmed publisher
  • western blot; rat; fig 3e
Rippe C, Zhu B, Krawczyk K, Bavel E, Albinsson S, Sjölund J, et al. Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway. Sci Rep. 2017;7:1334 pubmed publisher
Gutierrez C, Al Khafaji A, Brenner E, Johnson K, Gohil S, Lin Z, et al. Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment. Nat Cancer. 2021;2:758-772 pubmed publisher
Guo Q, Huang F, Qing Y, Feng S, Xiao X, Wang Y, et al. Decreased Jagged1 Expression in Vascular Smooth Muscle Cells Delays Endothelial Regeneration in Arteriovenous Graft. Cardiovasc Res. 2020;: pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.